BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $79,675,072 | +48.2% | 739,238 | +30.5% | 0.01% | +30.0% |
Q1 2024 | $53,752,799 | -1.0% | 566,654 | -3.8% | 0.01% | 0.0% |
Q4 2023 | $54,315,985 | +204.2% | 588,855 | +65.6% | 0.01% | +150.0% |
Q3 2023 | $17,854,114 | -29.4% | 355,518 | -11.2% | 0.00% | -20.0% |
Q2 2023 | $25,289,859 | +63.0% | 400,156 | +16.0% | 0.01% | +66.7% |
Q1 2023 | $15,516,646 | +11.6% | 344,891 | +8.7% | 0.00% | 0.0% |
Q4 2022 | $13,899,249 | +65299.0% | 317,262 | -1.6% | 0.00% | -40.0% |
Q3 2022 | $21,253 | +63.0% | 322,550 | +24.9% | 0.01% | +66.7% |
Q2 2022 | $13,038 | -99.9% | 258,144 | -15.9% | 0.00% | -25.0% |
Q1 2022 | $19,597,000 | -54.3% | 306,776 | -23.4% | 0.00% | -55.6% |
Q4 2021 | $42,895,000 | -31.9% | 400,471 | -34.7% | 0.01% | -30.8% |
Q3 2021 | $63,030,000 | +30.2% | 613,065 | +11.4% | 0.01% | +18.2% |
Q2 2021 | $48,411,000 | +2.0% | 550,380 | +12.7% | 0.01% | -8.3% |
Q1 2021 | $47,469,000 | -25.7% | 488,213 | -14.3% | 0.01% | -25.0% |
Q4 2020 | $63,867,000 | +33.7% | 569,478 | +10.5% | 0.02% | +14.3% |
Q3 2020 | $47,776,000 | +8.6% | 515,373 | -8.6% | 0.01% | +16.7% |
Q2 2020 | $43,995,000 | +23.5% | 564,035 | -7.4% | 0.01% | -7.7% |
Q1 2020 | $35,613,000 | +15.6% | 608,977 | +58.3% | 0.01% | +62.5% |
Q4 2019 | $30,815,000 | +14.8% | 384,665 | +5.3% | 0.01% | 0.0% |
Q3 2019 | $26,851,000 | -19.2% | 365,473 | +3.8% | 0.01% | -20.0% |
Q2 2019 | $33,213,000 | +3.3% | 352,089 | -12.4% | 0.01% | 0.0% |
Q1 2019 | $32,165,000 | +56.9% | 401,818 | +5.6% | 0.01% | +25.0% |
Q4 2018 | $20,504,000 | -37.4% | 380,360 | -9.3% | 0.01% | 0.0% |
Q3 2018 | $32,744,000 | +45.4% | 419,479 | +18.3% | 0.01% | +33.3% |
Q2 2018 | $22,515,000 | -19.3% | 354,673 | +16.5% | 0.01% | -14.3% |
Q1 2018 | $27,914,000 | +90.4% | 304,408 | +56.6% | 0.01% | +75.0% |
Q4 2017 | $14,663,000 | -6.7% | 194,439 | -13.8% | 0.00% | 0.0% |
Q3 2017 | $15,709,000 | +18.9% | 225,473 | -13.5% | 0.00% | 0.0% |
Q2 2017 | $13,215,000 | -6.5% | 260,792 | -26.2% | 0.00% | 0.0% |
Q1 2017 | $14,139,000 | +440.3% | 353,556 | +278.9% | 0.00% | +300.0% |
Q4 2016 | $2,617,000 | +178.4% | 93,309 | +194.9% | 0.00% | – |
Q3 2016 | $940,000 | -85.0% | 31,637 | -90.9% | 0.00% | -100.0% |
Q1 2016 | $6,268,000 | -39.6% | 347,238 | -11.8% | 0.00% | -33.3% |
Q4 2015 | $10,371,000 | +4959.0% | 393,719 | +3992.7% | 0.00% | – |
Q3 2015 | $205,000 | -59.0% | 9,620 | -49.0% | 0.00% | – |
Q2 2015 | $500,000 | – | 18,867 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |